<unk> , sold under the brand name Serdolect among others, is an antipsychotic medication.<unk>  was developed by the Danish pharmaceutical company Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative.<unk>  is not approved for use in the United States and was discontinued in Australia in January 2014.
Sertindole
Iprindole
Pirlindole
Butriptyline
Bromocriptine
Influenzanet
Haloperidol
Ropinirole